P3 Health PartnersPIII
PIII
About: P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Employees: 400
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
3.93% less ownership
Funds ownership: 23.76% [Q2] → 19.83% (-3.93%) [Q3]
23% less funds holding
Funds holding: 60 [Q2] → 46 (-14) [Q3]
28% less capital invested
Capital invested by funds: $17.2M [Q2] → $12.4M (-$4.86M) [Q3]
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$0.25
21%
upside
Avg. target
$0.25
21%
upside
High target
$0.25
21%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
TD Cowen Gary Taylor 26% 1-year accuracy 5 / 19 met price target | 21%upside $0.25 | Hold Maintained | 20 Nov 2024 |
Financial journalist opinion
Neutral
Business Wire
1 week ago
P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California. Management will give a presentation on Tuesday, January 14, 2024, at 7:30 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay wi.
Neutral
PRNewsWire
1 month ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
NEW YORK , Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Neutral
Business Wire
1 month ago
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time. A live webcast of the presentation will be available the following day on P3's Investor Relations Website: https://ir.p3.
Neutral
Business Wire
2 months ago
P3 Health Partners to Participate in Upcoming Investor Conferences
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company will participate in the following upcoming investor conferences: - The 3rd Annual Needham Virtual Healthcare IT 1x1 Conference on Wednesday, November 20, 2024 - The BTIG Digital Health Forum on Monday, November 25, 2024 About P3 Health Partners (NASDAQ: PIII) P3 Health Partners Inc. is a leading p.
Neutral
Seeking Alpha
2 months ago
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Leif Pedersen - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Jack Senft - William Blair Operator Good day, and welcome to P3 Health Partners Third Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
Negative
Zacks Investment Research
2 months ago
P3 Health Partners Inc. (PIII) Reports Q3 Loss, Misses Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Neutral
Business Wire
2 months ago
P3 Health Partners Announces Third Quarter 2024 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024. “As we execute on our strategic initiatives, we believe P3 will be well-positioned to unlock the value built within our platform and generate sustainable, profitable growth in the medium and long term,” said Aric Coffman, CEO of P3. “We hav.
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
Neutral
Accesswire
2 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partners
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
Charts implemented using Lightweight Charts™